argenx SE (ARGX)
981.33
+3.75
(+0.38%)
USD |
NASDAQ |
Nov 12, 16:00
980.52
-0.81
(-0.08%)
After-Hours: 20:00
argenx Price : 981.33 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 976.89 | 988.89 | 964.86 | 981.33 | 449423.0 |
| Nov 11, 2026 | 966.35 | 980.55 | 962.33 | 977.58 | 246245.0 |
| Nov 10, 2026 | 964.97 | 976.44 | 958.60 | 971.55 | 434071.0 |
| Nov 09, 2026 | 945.59 | 966.18 | 935.56 | 962.27 | 442904.0 |
| Nov 06, 2026 | 894.78 | 929.88 | 892.36 | 927.21 | 379269.0 |
| Nov 05, 2026 | 928.33 | 928.33 | 892.84 | 894.77 | 399493.0 |
| Nov 04, 2026 | 922.71 | 933.38 | 895.49 | 931.38 | 645892.0 |
| Nov 03, 2026 | 874.09 | 903.27 | 873.32 | 901.12 | 432226.0 |
| Nov 02, 2026 | 893.27 | 899.12 | 872.50 | 874.97 | 301318.0 |
| Oct 30, 2026 | 896.79 | 916.05 | 890.01 | 892.87 | 462446.0 |
| Oct 29, 2026 | 898.98 | 907.25 | 894.41 | 897.85 | 160887.0 |
| Oct 28, 2026 | 873.08 | 897.03 | 870.21 | 891.76 | 193373.0 |
| Oct 27, 2026 | 864.81 | 882.60 | 859.32 | 882.48 | 290153.0 |
| Oct 26, 2026 | 876.46 | 884.18 | 864.11 | 869.33 | 269569.0 |
| Oct 23, 2026 | 875.98 | 887.07 | 865.72 | 873.70 | 298966.0 |
| Oct 22, 2026 | 853.28 | 897.27 | 853.28 | 875.76 | 1.021M |
| Oct 21, 2026 | 875.27 | 892.85 | 873.22 | 890.05 | 656687.0 |
| Oct 20, 2026 | 847.53 | 881.10 | 843.51 | 869.72 | 536450.0 |
| Oct 19, 2026 | 815.56 | 828.69 | 814.40 | 825.61 | 394794.0 |
| Oct 16, 2026 | 842.80 | 843.61 | 813.05 | 819.14 | 389020.0 |
| Oct 15, 2026 | 842.46 | 858.21 | 838.78 | 846.27 | 510768.0 |
| Oct 14, 2026 | 809.03 | 835.31 | 803.00 | 818.30 | 464121.0 |
| Oct 13, 2026 | 817.16 | 822.28 | 798.48 | 802.64 | 277152.0 |
| Oct 12, 2026 | 832.33 | 832.49 | 810.70 | 812.30 | 241201.0 |
| Oct 09, 2026 | 821.96 | 826.78 | 805.07 | 825.03 | 512248.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Autolus Therapeutics Plc | 1.19 |
| Cellectis SA | 1.33 |
| Halozyme Therapeutics, Inc. | 100.67 |
| DBV Technologies SA | 11.43 |
| Akari Therapeutics Plc | 6.51 |
Price Related Metrics
| PE Ratio | 37.40 |
| PS Ratio | 12.27 |
| Price to Free Cash Flow | 58.82 |
| Earnings Yield | 2.67% |
| Market Cap | 60.73B |
| Operating PE Ratio | 42.57 |
| Normalized PE Ratio | 37.40 |